Par Health makes essential medicines, including active pharmaceutical ingredients, generic drugs and sterile injectables, through a global manufacturing network. Formed from the merger of Mallinckrodt and Endo, the company carries more than 160 years of pharmaceutical experience, including a St. Louis API site with roots reaching back over 160 years. With 10 manufacturing facilities, two R&D centers and products reaching more than 70 countries, Par Health combines that long industrial history with a broad modern supply network.
Global Compliance Program
compliance_program
US cGMP
compliance_program
International Regulatory Standards
compliance_program
LEED certifications
certification
Supplier Code of Conduct
compliance_program
Paragon MedicalParagon Medical brings more than a century of combined medical-manufacturing expertise to its work as a global contract design and manufacturing organization for medical-device companies. Its vertically integrated operations support customers from product development through commercialization, with ISO 13485:2016-compliant facilities across its worldwide network.DAYTON, OH
Xellia PharmaceuticalsWith more than 120 years devoted to anti-infectives, Xellia Pharmaceuticals develops and manufactures fermentation-based non-beta-lactam medicines, supplying APIs and finished dosage forms for severe infections. Based in Copenhagen with manufacturing in Europe and Asia, it is one of the last Western producers of several essential anti-infective APIs and supplies more than 500 pharmaceutical companies across 80 countries. Its defining focus is continuity: keeping complex, critical medicines available through long-term manufacturing expertise and investment.CLEVELAND, OH
ActylisWith more than 75 years in the trade, Actylis sources and manufactures critical ingredients and raw materials for pharmaceutical, biopharmaceutical, nutrition and specialty-chemical makers. Its global network combines in-house production with tailored sourcing, process development and supply-chain support, including a 30,000-square-foot cGMP API facility in Eugene and Water for Injection capabilities in Montreal. Actylis operates ISO 9001:2015-certified facilities and supports customers from early development through commercial-scale production.GRAND ISLAND, NY
SandozSandoz develops and manufactures off-patent generic and biosimilar medicines, making established treatments more affordable and accessible to patients worldwide. The company pioneered biosimilar development in 2006 and now has around 1,500 generics in its portfolio, with its production network supporting more than one billion patient treatments each year. Its history of pharmaceutical innovation reaches back to the first oral penicillin in 1951.MELVILLE, NY